We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Janssen Sues Sandoz Over Alzheimer's Drug Patent

Law360 (August 18, 2008, 12:00 AM EDT) -- Two Johnson & Johnson subsidiaries and their licensing partner have launched a patent infringement suit against Novartis AG’s generics arm, Sandoz Inc., after the generics maker filed an abbreviated new drug application for Razadyne, a drug used to treat Alzheimer's.

In a complaint filed Aug. 13 in the U.S. District Court for the District of Delaware, Janssen Pharmaceutica, Ortho-McNeil-Janssen Pharmaceuticals Inc. and Synaptech Inc. allege that Sandoz's ANDA falls within one or more claims of a patent pertaining to a method of treatment of Alzheimer’s....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.